Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...